Search Within

Brandon Stuart Imber

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (22)
  2. Journal Article (8)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Bone Marrow Transplant (32)
  2. CTCR Scholars (32)
  3. Center for Hematologic Malignancies (32)
  4. Department of Medicine (32)
  5. Hematologic Malignancies, Division of (32)
  6. MSK Grad Students (32)

More Groups

People
  1. Parastoo Dahi (31)
  2. Miguel-Angel Perales (30)
  3. Gunjan Shah (29)
  4. Maria Palomba (29)
  5. Michael Scordo (29)
  6. Joachim Yahalom (25)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (9)
  4. 2022 (4)
  5. 2021 (4)
  6. 2020 (3)

More Years

Publications
  1. Blood (10)
  2. Hematological Oncology (4)
  3. International Journal of Radiation Oncology, Biology, Physics (4)
  4. Transplantation and Cellular Therapy (3)
  5. Journal of Hematology & Oncology (2)
  6. Leukemia and Lymphoma (2)

More Publications

Publishers
  1. American Society of Hematology (11)
  2. Elsevier Inc. (7)
  3. Wiley Blackwell (4)
  4. Nature Publishing Group (3)
  5. Biomed Central Ltd (2)
  6. Taylor & Francis Group (2)

More Publishers

Results (32)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma
    Journal Article

    Luna, A.; Devlin, S. M.; Rejeski, K.; Flynn, J. R.; Corona, M.; Luttwak, E.; Rivas-Delgado, A.; Landego, I.; Cassanello, G.; Gomez-Llobell, M.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Severe toxicity, but long-term persistence of CAR T cells after immune checkpoint inhibitors in large B-cell lymphoma
    Research Letter

    Deschenes-Simard, X.; Pennisi, M.; Perales, M. A.; Shah, G. L.; Zelenetz, A. D.; Yahalom, J.; Imber, B. S.; Santomasso, B. D.; Dahi, P. B.
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Site-specific responses and extranodal involvement implications in large B-cell lymphomas treated with CD19-CART therapy
    Meeting Abstract

    Luna de Abia, A.; Devlin, S. M.; Flynn, J.; Corona De Lapuerta, M.; Luttwak, E.; Landego, I.; Dahi, P. B.; Lin, R. J.; Parascondola, A.; Palomba, M. L.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • A proof-of-principle study of split-course bridging radiotherapy (SC-BRT) prior to commercial CAR T-cell therapies for relapsed or refractory B-cell lymphomas: Results from phase 1a pilot cohort
    Meeting Abstract

    Imber, B. S.; Palomba, M. L.; Brosoff, A.; Roszak, E.; McAvoy, D.; Hosszu, K.; Boardman, A.; Dahi, P. B.; Lin, R. J.; Shah, G. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Improvement in radiomic features following bridging therapy is prognostic for CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H. G.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Boardman, A.; Dahi, P. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas
    Journal Article

    Cederquist, G. Y.; Schefflein, J.; Devlin, S. M.; Shah, G. L.; Shouval, R.; Hubbeling, H.; Tringale, K.; Tomas, A. A.; Fregonese, B.; Hajj, C.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
    Journal Article

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Zheng, J.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; more...
    Journal of Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Impact of response to systemic bridging therapy on clinical outcomes and cytokine profiles in patients receiving CD19-CAR T-cell therapy for B-cell lymphoma
    Meeting Abstract

    Wills, B.; Shouval, R.; Flynn, J. R.; Devlin, S. M.; Parascondola, A.; Saldia, A.; Imber, B. S.; Tomas, A. A.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save